A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms

Clinical trial NCT02842229 · COMPLETED

Trial details

NCT number: NCT02842229
Sponsor: Celgene
Status: COMPLETED
Study type: OBSERVATIONAL

Myelodysplastic Syndromes Leukemia Myeloid Acute Multiple Myeloma Leukemia, Lymphocytic, Chronic, B-Cell

Start date: 2016-07-20
Primary completion: 2017-02-02
Enrollment: 117

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.